FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/11/2022
Back to search
Official data from USPTO
GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE.
ST13
US500000079300854Class
41, 42, 44
Filing
79300854
Registration
6674439
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/11/2022
Trademark type
Word
Nice classes
41, 42, 44
Filing date
09/22/2020
Registration date
03/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
BE
Examiner
DYER, ERIN ZASKODA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Galapagos N.V.
Representatives
Alexandra MacKay Stites & Harbison, PLLC
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Education servicesorganizing and conducting conferencesseminarsworkshops and classes in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith; provision of trainingprovision of training in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals for the treatment of medical disorders and dissemination of materials in connection therewith
Class 42
Medical and scientific research services; industrial research services in the field of assay developmenttarget discovery and validationdrug developmentmedicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific researchthe examination and testing of genes; developmentlaboratory analysistesting of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; developmentlaboratory analysistesting of medicaments; the development of clinical assayscellular teststesting kitsdiagnostic kitscompanion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medicalpharmaceutical and biopharmaceutical fields; development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services
Class 44
Medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
Publications
History of USPTO decisions and trademark events.
33 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/12/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
08/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/15/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2021
ALIE
ASSIGNED TO LIE
10/28/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/23/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/01/2021
GNSL
LETTER OF SUSPENSION E-MAILED
10/01/2021
CNSL
SUSPENSION LETTER WRITTEN
10/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/30/2021
RFNT
REFUSAL PROCESSED BY IB
03/22/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/02/2021
RFRR
REFUSAL PROCESSED BY MPU
03/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/23/2021
CNRT
NON-FINAL ACTION WRITTEN
02/22/2021
DOCK
ASSIGNED TO EXAMINER
02/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens GALAPAGOS. PIONEERING FOR PATIENTS. WE DISCOVER. WE DARE. WE CARE. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.